The Coulter Beckamn conference with Dr. Patterson

The Coulter Beckamn conference with Dr. Patterson was very telling (more so than the TEDTalk) as it revealed a ton of new data that had been unpublished.

I was always wondering why the C-Reactive Protein (CRP) measurements had not been included in the paper. I actually think that the trials should had included a CRP panel rather than other outcomes (for example myalgia).

However, Dr. Yang made measurements with his patients in Southern California:

https://drive.google.com/file/d/1o2YkSxYb0ijE...sp=sharing

All patients but one show reduction trends (actually Dr. Yang commented on this on his presentation).

And, in the Beckman Coulter conference Dr. Patterson showed a panel of results including CRP (please see f) which I have seen for the first time:

https://drive.google.com/file/d/1ru_A49Cd6uwa...sp=sharing

All the patients but one show reduction (dramatic in one of the patients) more noticeable 7 days after Leronlimab injection.

CRP is produced by the liver in response to inflammation. A high level of CRP in the blood is a good marker of the status of inflammation, sometimes as is fever. Reduction of these level normally indicate that the patient's fight against the virus is being won by the immune system. The timing, just after Leronlimab injection, points once more to that unavoidable fact that the drug is directly responsible for the improvement.

As if we needed more proof ... sorry to state the obvious.